SenesTech Inc. (NASDAQ: SNES) Posts Fiscal Year 2023 Results; Reports Revenue Growth, and Gross Margin and Operating Expense Improvement
This success has been attributed largely to the company’s development and recent release of its Evolve soft bait product, a key addition to its growing product line Year to date 2024, SenesTech reported 80% year-to-date revenue growth compared to the same period in 2023 Going forward, the company looks to introduce a soft bait contraceptive product for mice, having proven that its products work effectively…